Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
The planning station's printed plan report may indicate dose statistics which are not correct. treatments internal to tomotherapy's hi-art treatment system are not approved based on printed plan report dose statistics. however if erroneous dose statistics were provided to third parties to guide therapy in re-treatment situations improper therapy could result.